Jon E. Angell

Array ( [id] => 23892 [patent_doc_number] => 07795233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Composition comprising double stranded RNA that inhibits expression of NEU3 and method for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/719517 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7155 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795233.pdf [firstpage_image] =>[orig_patent_app_number] => 11719517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397843 [patent_doc_number] => 20090317906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'GENE SILENCING USING SENSE DNA AND ANTISENSE RNA HYBRID CONSTRUCTS COUPLED TO PEPTIDES FACILITATING THE UPTAKE INTO CELLS' [patent_app_type] => utility [patent_app_number] => 11/719235 [patent_app_country] => US [patent_app_date] => 2005-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6663 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317906.pdf [firstpage_image] =>[orig_patent_app_number] => 11719235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613527 [patent_doc_number] => 20060115455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Therapeutic RNAi agents for treating psoriasis' [patent_app_type] => utility [patent_app_number] => 11/256666 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21804 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115455.pdf [firstpage_image] =>[orig_patent_app_number] => 11256666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5521950 [patent_doc_number] => 20090029931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Topical administrations of antisense compounds to vla-4 for the treatment of respiratory conditions' [patent_app_type] => utility [patent_app_number] => 11/666001 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16391 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029931.pdf [firstpage_image] =>[orig_patent_app_number] => 11666001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720354 [patent_doc_number] => 20060073128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Means and methods for the modulation of arteriogenesis' [patent_app_type] => utility [patent_app_number] => 11/252623 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7269 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073128.pdf [firstpage_image] =>[orig_patent_app_number] => 11252623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070168 [patent_doc_number] => 20070191270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/234694 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 116 [patent_figures_cnt] => 116 [patent_no_of_words] => 40762 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191270.pdf [firstpage_image] =>[orig_patent_app_number] => 11234694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113201 [patent_doc_number] => 08569374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'NADPH oxidase inhibition pharmacotherapies for obstructive sleep apnea syndrome and its associated morbidities' [patent_app_type] => utility [patent_app_number] => 11/226471 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13022 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11226471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436207 [patent_doc_number] => 20090170794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Small interfering rnas that efficiently inhibit viral expression and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/662506 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 11282 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170794.pdf [firstpage_image] =>[orig_patent_app_number] => 11662506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4570028 [patent_doc_number] => 07858590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Treatment of parkinson\'s disease and related disorders' [patent_app_type] => utility [patent_app_number] => 11/572397 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20671 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858590.pdf [firstpage_image] =>[orig_patent_app_number] => 11572397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624303 [patent_doc_number] => 08003599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Inhibitors of L1 and ADAM10 for the treatment of carcinomas' [patent_app_type] => utility [patent_app_number] => 11/573269 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 13 [patent_no_of_words] => 9610 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003599.pdf [firstpage_image] =>[orig_patent_app_number] => 11573269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694740 [patent_doc_number] => 20060154887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Use of apoptosis-specific eIF-5A siRNAs and antisense polynucleotides to inhibit/suppress an inflammatory response' [patent_app_type] => utility [patent_app_number] => 11/184982 [patent_app_country] => US [patent_app_date] => 2005-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 139 [patent_figures_cnt] => 139 [patent_no_of_words] => 40445 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154887.pdf [firstpage_image] =>[orig_patent_app_number] => 11184982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5881454 [patent_doc_number] => 20060030537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Ceramide kinase and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/179958 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16326 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030537.pdf [firstpage_image] =>[orig_patent_app_number] => 11179958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14030 [patent_doc_number] => 07807815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA' [patent_app_type] => utility [patent_app_number] => 11/174453 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 33 [patent_no_of_words] => 29632 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807815.pdf [firstpage_image] =>[orig_patent_app_number] => 11174453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770595 [patent_doc_number] => 20050266486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Methods for treating obesity by inhibiting expression of obese gene product receptor variant' [patent_app_type] => utility [patent_app_number] => 11/166730 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5110 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266486.pdf [firstpage_image] =>[orig_patent_app_number] => 11166730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894831 [patent_doc_number] => 20060003370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/157996 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 36958 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003370.pdf [firstpage_image] =>[orig_patent_app_number] => 11157996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726356 [patent_doc_number] => 20060057116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Recombinant influenza viruses for vaccines and gene therapy' [patent_app_type] => utility [patent_app_number] => 11/150631 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13873 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057116.pdf [firstpage_image] =>[orig_patent_app_number] => 11150631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895419 [patent_doc_number] => 20060003958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Novel polynucleotides related to oligonucleotide arrays to monitor gene expression' [patent_app_type] => utility [patent_app_number] => 11/128061 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22322 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003958.pdf [firstpage_image] =>[orig_patent_app_number] => 11128061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7046100 [patent_doc_number] => 20050250695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Combination PDGF, KGF, IGF, and IGFBP for wound healing' [patent_app_type] => utility [patent_app_number] => 11/120154 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12941 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250695.pdf [firstpage_image] =>[orig_patent_app_number] => 11120154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4460038 [patent_doc_number] => 07879610 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-02-01 [patent_title] => 'Electroporation system and method for facilitating entry of molecules into cells in vivo' [patent_app_type] => utility [patent_app_number] => 10/907631 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3531 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879610.pdf [firstpage_image] =>[orig_patent_app_number] => 10907631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9440910 [patent_doc_number] => 08710020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Clusterin antisense therapy for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/470331 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6009 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11470331 [rel_patent_id] =>[rel_patent_doc_number] =>)